Hepatic arterial infusion chemotherapy for hepatocellular carcinoma with tumor thrombosis of the portal vein tumor thrombosis

Figure 1 Cumulative survival for 18 hepatocellular carcinoma patients with portal vein tumor thrombosis undergoing hepatic arterial infusion chemotherapy. The 3, 6, 9, 12, 15 and 18-month cumulative survival rates for the 18 patients were 83%, 72%, 50%, 28%, 14%, and 7%, respectively.

Figure 2 Image study using abdominal computed tomogra-phy (hepatic artery phase) of an HCC patient with good partial response to hepatic arterial infusion chemotherapy (HAIC) shows a marked decrease in tumor size from 14 × 10 × 9 cm (A: before HAIC) to 9 × 8 × 7 cm (B: 1. 5 months after initiation of HAIC) and 5 × 5 × 3 cm (C: 4 months after initiation of HAIC).